ARCHIVES

NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System

This article is from The Cancer Letter archive.

Vol. 23 No. 46 | December 5, 1997

Download PDF Visit The Full Archive

Related Articles

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

NCCS Networker Volume 11 Issue 2, Summer 1997

June 13, 1997

NCI-Approved Clinical Trials

December 30, 2005

NCI Reportedly Gets $691 Million From House, Senate Conferees

October 4, 1974

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013